937
Views
5
CrossRef citations to date
0
Altmetric
Cognition and attitudes

Attitudes towards prediction and early diagnosis of late-onset dementia: a comparison of tested persons and family caregivers

, &
Pages 832-843 | Received 25 Sep 2019, Accepted 05 Feb 2020, Published online: 24 Feb 2020

References

  • Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., … Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer's & Dementia, 7(3), 270–279. doi:10.1016/j.jalz.2011.03.008
  • Batsch, N., & Mittelman, M. S. (2012). World Alzheimer Report 2012. Overcoming the Stigma of Dementia. London, UK: Alzheimer’s Disease International.
  • Beard, R. L., & Neary, T. M. (2013). Making sense of nonsense: Experiences of mild cognitive impairment. Sociology of Health & Illness, 35(1), 130–146. doi:10.1111/j.1467-9566.2012.01481.x
  • Bengtsson, M. (2016). How to plan and perform a qualitative study using content analysis. NursingPlus Open, 2, 8–14. doi:10.1016/j.npls.2016.01.001
  • Butler, M., McCreedy, E., Nelson, V. A., Desai, P., Ratner, E., Fink, H. A., … Kane, R. L. (2018). Does cognitive training prevent cognitive decline?: A systematic review. Annals of Internal Medicine, 168(1), 63–68. doi:10.7326/M17-1531
  • Corrigan, P. W., & Rao, D. (2012). On the self-stigma of mental illness: Stages, disclosure, and strategies for change. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 57(8), 464–469. doi:10.1177/070674371205700804
  • Davis, D. S. (2014). Alzheimer disease and pre-emptive suicide. Journal of Medical Ethics, 40(8), 543–549. doi:10.1136/medethics-2012-101022
  • Deuschl, G., & Maier, W. (2016). S3-Leitlinie “Demenzen”. Retrieved from https://www.awmf.org/uploads/tx_szleitlinien/038-013l_S3-Demenzen-2016-07.pdf
  • Deutsche Alzheimer Gesellschaft e.V. (2014). Mit Demenz zu Hause leben: Möglichkeiten der ambulanten Versorgung für Menschen mit Demenz. Alzheimer Info. Retrieved from https://www.deutsche-alzheimer.de/unser-service/archiv-alzheimer-info/mit-demenz-zu-hause-leben-moeglichkeiten-der-ambulanten-versorgung-fuer-menschen-mit-demenz.html
  • Deutsche Alzheimer Gesellschaft e.V. (2018). Informationsblatt 3: Die Diagnose der Alzheimer Erkrankung und anderer Demenz Erkrankungen. Informationsblätter. Retrieved from https://www.deutsche-alzheimer.de/fileadmin/alz/pdf/factsheets/infoblatt3_diagnose_dalzg.pdf
  • Deutsche Alzheimer Gesellschaft e.V. (2019). Gedächtnissprechstunden. Retrieved from http://www.deutsche-alzheimer.de/unser-service/gedaechtnissprechstunden.html
  • Dresser, R. (2014). Pre-emptive suicide, precedent autonomy and preclinical Alzheimer disease. Journal of Medical Ethics, 40(8), 550–551. doi:10.1136/medethics-2013-101615
  • Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., … Scheltens, P. (2010). Revising the definition of Alzheimer’s disease: A new lexicon. Lancet Neurology., 9(11), 1118–1127. doi:10.1016/S1474-4422(10)70223-4
  • Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., & Jack, C. R. Jr.(2016). Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Alzheimer's & Dementia, 12(3), 292–323., doi:10.1016/j.jalz.2016.02.002
  • Eschweiler, G., Leyhe, T., Klöppel, S., & Hüll, M. (2010). Neue Entwicklungen in der Demenz Diagnostik. [New developments in dementia diagnostics.]. Deutsches Ärzteblatt, 107, 677–683.
  • Fang, M. L., Coatta, K., Badger, M., Wu, S., Easton, M., Nygård, L., … Sixsmith, A. (2017). Informing Understandings of Mild Cognitive Impairment for Older Adults: Implications From a Scoping Review. Journal of Applied Gerontology, 36(7), 808–839. doi:10.1177/0733464815589987
  • Fink, H. A., Jutkowitz, E., McCarten, J. R., Hemmy, L. S., Butler, M., Davila, H., … Kane, R. L. (2018). Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: A systematic review. Annals of Internal Medicine, 168(1), 39–51. doi:10.7326/M17-1529
  • Ganguli, M., Snitz, B. E., Saxton, J. A., Chang, C.-C. H., Lee, C.-W., Vander Bilt, J., … Petersen, R. C. (2011). Outcomes of mild cognitive impairment by definition: A population study. Archives of Neurology, 68(6), 761–767. doi:10.1001/archneurol.2011.101
  • Gaskell, G. (2000). Individuals and groups interviewing. In G. G. Bauer MV (Ed.), Qualitative Researching with test, image and sound: A practical handbook (pp. 38–56). London: Sage.
  • Gilleard, C., & Higgs, P. (2014). Studying dementia: The relevance of the fourth age. Quality in Ageing and Older Adults, 15(4), 241–243. doi:10.1108/QAOA-10-2014-0027
  • Graham, J. R. K. (2006). Mild cognitive impairment: Ethical considerations for nosological flexibility in human kinds. Philosophy, Psychiatry & Psychology, 13, 31–43. doi:10.1353/ppp.2006.0039
  • Harvard School of Public Health & Alzheimer Europe. (2011). Five-country Alzheimer’s disease survey. Retrieved from https://www.alzheimer-europe.org/Research/Value-of-Knowing
  • Haw, C., Harwood, D., & Hawton, K. (2009). Dementia and suicidal behavior: A review of the literature. International Psychogeriatrics, 21(3), 440–453. doi:10.1017/S1041610209009065
  • Herrmann, L. K., Welter, E., Leverenz, J., Lerner, A. J., Udelson, N., Kanetsky, C., & Sajatovic, M. (2018). A systematic review of dementia-related stigma research: Can we move the stigma dial? The American Journal of Geriatric Psychiatry, 26(3), 316–331. doi:10.1016/j.jagp.2017.09.006
  • IfD Allensbach. (2016). ROLAND Rechtsreport 2016 - Vorbereitung der Bevölkerung auf eine mögliche Pflegebedürftigkeit und ihre Einstellung zur aktiven und passiven Sterbehilfe [ROLAND legal report - Preparation of the population for a possible need for long-term care and its attitude to active and passive euthanasia].Köln: ROLAND Rechtsschutz-Versicherungs-AG.
  • Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., … Phelps, C. H. (2011). Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer's & Dementia, 7(3), 257–262. doi:10.1016/j.jalz.2011.03.004
  • Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., … Dubois, B. (2016). A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology, 87(5), 539–547. doi:10.1212/WNL.0000000000002923
  • Jellinger, K. A. (2006). Clinicopathological analysis of dementia disorders in the elderly–an update. Journal of Alzheimer's Disease, 9(s3), 61–70. doi:10.3233/JAD-2006-9S308
  • Jessen, F. (2019). Früherkennung der Alzheimer-Krankheit und Ansätz der Prävention. [Early detection of Alzheimer’s disease and approaches for prevention. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 62(3), 255–260.]. doi:10.1007/s00103-019-02877-2
  • Johnson, R., Harkins, K., Cary, M., Sankar, P., & Karlawish, J. (2015). The relative contributions of disease label and disease prognosis to Alzheimer’s stigma: A vignette-based experiment. Social Science & Medicine, 143, 117–127. doi:10.1016/j.socscimed.2015.08.031
  • Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., … Thies, W. H. (2013). Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association. Journal of Nuclear Medicine, 54(3), 476–490. doi:10.2967/jnumed.113.120618
  • Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., … Antuono, P, … for the World Federation of Neurology Dementia Research Group. (2008). Alzheimer’s disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurology, 7(9), 812–826. doi:10.1016/S1474-4422(08)70169-8
  • Karlawish, J. (2011). Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease. Neurology, 77(15), 1487–1493. doi:10.1212/WNL.0b013e318232ac1a
  • Krippendorff, K. (2013). Content analysis: an introduction to its methodology (3rd ed.). Los Angeles, CA: .Sage.
  • Leibing, A. (2018). Situated prevention: Framing the “new dementia”. The Journal of Law, Medicine & Ethics, 46(3), 704–716. doi:10.1177/1073110518804232
  • Lingler, J. H., Butters, M. A., Gentry, A. L., Hu, L., Hunsaker, A. E., Klunk, W. E., … Schulz, R. (2016). Development of a standardized approach to disclosing amyloid imaging research results in mild cognitive impairment. Journal of Alzheimer's Disease, 52(1), 17–24. doi:10.3233/JAD-150985
  • Lock, M. M. (2013). The Alzheimer conundrum: entanglements of dementia and aging. Princeton, NJ: Princeton University Press.
  • Lorig, K. R., & Holman, H. (2003). Self-management education: History, definition, outcomes, and mechanisms. Annals of Behavioral Medicine, 26(1), 1–7. doi:10.1207/S15324796ABM2601_01
  • Luck, T., Luppa, M., Sieber, J., Schomerus, G., Werner, P., Konig, H. H., & Riedel-Heller, S. G. (2012). Attitudes of the German general population toward early diagnosis of dementia–results of a representative telephone survey. PLoS One., 7(11), e50792. doi:10.1371/journal.pone.0050792
  • Malek-Ahmadi, M. (2016). Reversion from mild cognitive impairment to normal cognition: A meta-analysis. Alzheimer Disease & Associated Disorders, 30(4), 324–330. doi:10.1097/WAD.0000000000000145
  • Mattsson, N., Brax, D., & Zetterberg, H. (2010). To know or not to know: Ethical issues related to early diagnosis of Alzheimer’s disease. International Journal of Alzheimer's Disease, Article ID 841941. doi:10.4061/2010/841941
  • Metschke, R., & Wellbrock, R. (2002). Datenschutz in Wissenschaft und Forschung (3rd ed.). Berlin: Berliner Beauftragter Für Datenschutz Und Informationsfreiheit.
  • Milne, R., Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., … Brayne, C. (2018). Perspectives on communicating biomarker-based assessments of Alzheimer’s disease to cognitively healthy individuals. Journal of Alzheimer's Disease, 62(2), 487–498. doi:10.3233/JAD-170813
  • Mitchell, A. J., & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119(4), 252–265. doi:10.1111/j.1600-0447.2008.01326.x
  • Mozersky, J., Sankar, P., Harkins, K., Hachey, S., & Karlawish, J. (2018). Comprehension of an Elevated amyloid positron emission tomography biomarker result by cognitively normal older adults. JAMA Neurology, 75(1), 44–50. doi:10.1001/jamaneurol.2017.2954
  • Nationaler Ethikrat. (2006). Selbstbestimmung und Fürsorge am Lebensende - Stellungsnahme [Self-determination and care at the end of one’s life – A statement of position]. Berlin: Nationaler Ethikrat.
  • Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303–308. doi:10.1001/archneur.56.3.303
  • Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., & Jucker, M. (2019). Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nature Medicine, 25(2), 277–283. doi:10.1038/s41591-018-0304-3
  • Prince, M., Wimo, A., Guerchet, M., Ali, G. C., Wu, Y. T., & Prina, M. (2015). World Alzheimer report 2015. The global impact of dementia. An analysis pf prevalence, incidence, cost and trends. London, UK: Alzheimer’s Disease International.
  • Rabinovici, G. D., Gatsonis, C., Apgar, C., Chaudhary, K., Gareen, I., Hanna, L., … Carrillo, M. C. (2019). Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA, 321(13), 1286–1294. doi:10.1001/jama.2019.2000
  • Rabins, P. V. (2007). Can suicide be a rational and ethical act in persons with early or pre-dementia?. The American Journal of Bioethics, 7(6), 47–49. doi:10.1080/15265160701347494
  • Robinson, S. M., Canavan, M., & O’Keeffe, S. T. (2014). Preferences of older people for early diagnosis and disclosure of Alzheimer’s disease (AD) before and after considering potential risks and benefits. Archives of Gerontology and Geriatrics, 59(3), 607–612.
  • Schicktanz, S., Schweda, M., Ballenger, J. F., Fox, P. J., Halpern, J., Kramer, J. H., … Jagust, W. J. (2014). Before it is too late: Professional responsibilities in late-onset Alzheimer’s research and pre-symptomatic prediction. Frontiers in Human Neuroscience., 8, 921.
  • Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Li, Y., Gordon, B. A., …., Bateman, R. J. (2019). High-precision plasma beta-amyloid 42/40 predicts current and future brain amyloidosis. Neurology, 93(17), e1647–e1659.
  • Schweda, M., Kogel, A., Bartels, C., Wiltfang, J., Schneider, A., & Schicktanz, S. (2018). Prediction and early detection of Alzheimer’s dementia: Professional disclosure practices and ethical attitudes. Journal of Alzheimer's Disease, 62(1), 145–155. doi:10.3233/JAD-170443
  • Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., … Phelps, C. H. (2011). Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer's & Dementia, 7(3), 280–292. doi:10.1016/j.jalz.2011.03.003
  • Steller, S. (2019). Die rechtliche Problematik der aktiven direkten Sterbehilfe. In Ärztliche Suizidbeihilfe und aktive Sterbehilfe unter besonderer Berücksichtigung des §217 StGB (Vol. 120). [The juridical complexity of active direct euthanasia. In suicide assistance by doctors and active euthanasia with special consideration of §217 StGB]. Baden-Baden: Tectum.
  • Stites, S. D., Milne, R., & Karlawish, J. (2018). Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands)), 10, 285–300. doi:10.1016/j.dadm.2018.02.006
  • Taylor, S. J., Pinnock, H., Epiphaniou, E., Pearce, G., Parke, H. L., Schwappach, A., … Sheikh, A. (2014). A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: PRISMS - Practical systematic Review of Self-Management Support for long-term conditions. Health Services and Delivery Research, 2(53), 1–580. doi:10.3310/hsdr02530
  • Van der Burg, S., Schreuder, F. H. B. M., Klijn, C. J. M., & Verbeek, M. M. (2019). Valuing biomarker diagnostics for dementia care: Enhancing the reflection of patients, their care-givers and members of the wider public. Medicine, Health Care and Philosophy, 22(3), 439–451. doi:10.1007/s11019-018-09883-2
  • van Maurik, I. S., Slot, R. E. R., Verfaillie, S. C. J., Zwan, M. D., Bouwman, F. H., Prins, N. D., Teunissen, C. E., & van der Flier, W. M. (2019). Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project. Alzheimer's Research & Therapy, 11(1), 33. doi:10.1186/s13195-019-0487-y
  • Vanderschaeghe, G., Schaeverbeke, J., Bruffaerts, R., Vandenberghe, R., & Dierickx, K. (2017). Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context. Alzheimer's Research & Therapy, 9(1), 92. doi:10.1186/s13195-017-0321-3
  • Vos, S. J. B., Verhey, F., Frölich, L., Kornhuber, J., Wiltfang, J., Maier, W., Peters, O., & Visser, P. J. (2015). Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage. Brain, 138(5), 1327–1338. doi:10.1093/brain/awv029
  • Werner, P., Goldstein, D., & Heinik, J. (2011). Development and validity of the Family Stigma in Alzheimer's disease Scale (FS-ADS)). Alzheimer Disease and Associated Disorders, 25(1), 42–48. doi:10.1097/WAD.0b013e3181f32594
  • Werner, P., & Heinik, J. (2008). Stigma by association and Alzheimer's disease. Aging & Mental Health, 12(1), 92–99. doi:10.1080/13607860701616325
  • Werner, P., Karnieli-Miller, O., & Eidelman, S. (2013). Current knowledge and future directions about the disclosure of dementia: A systematic review of the first decade of the 21st century. Alzheimer's & Dementia, 9(2), e74–88. doi:10.1016/j.jalz.2012.02.006
  • Werner, P., & Korczyn, A. D. (2008). Mild cognitive impairment: Conceptual, assessment, ethical, and social issues. Clinical Interventions in Aging, 3(3), 413–420. doi:10.2147/CIA.S1825
  • Werner, P., Mittelman, M. S., Goldstein, D., & Heinik, J. (2012). Family stigma and caregiver burden in Alzheimer’s disease. The Gerontologist, 52(1), 89–97. doi:10.1093/geront/gnr117
  • Whitehouse, P. J., & Moody, H. R. (2006). Mild cognitive impairment: A ‘hardening of the categories? Dementia, 5(1), 11–25. doi:10.1177/1471301206059752
  • Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O., … Petersen, R. C. (2004). Mild cognitive impairment–beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256(3), 240–246. doi:10.1111/j.1365-2796.2004.01380.x
  • Witte, M., Barnes, J., Lingler, J., Agronin, M., Hochstetler, H., Healey, K., … Trzepacz, P. (2013). Testing the use of standardized scripts for disclosing ‘hypothetical/mock’ amyloid PET scan results to nondemented cognitively impaired patients and their care partners. Alzheimer’s & Dementia, 9(4), 131–132.
  • Wortmann, M. (2012). Dementia: A global health priority - highlights from an ADI and World Health Organization report. Alzheimer's Research & Therapy, 4(5), 40. doi:10.1186/alzrt143
  • Wu, Y.-T., Beiser, A. S., Breteler, M. M. B., Fratiglioni, L., Helmer, C., Hendrie, H. C., … Brayne, C. (2017). The changing prevalence and incidence of dementia over time - current evidence. Nature Reviews Neurology, 13(6), 327–339. doi:10.1038/nrneurol.2017.63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.